TETRA Technologies announced a public offering of 10,810,811 common shares priced at $9.25 each, aiming to raise funds for general corporate purposes, including part of the construction costs for its Arkansas bromine project. The offering includes a 30-day option for underwriters to purchase an additional 1,621,621 shares to cover over-allotments. The deal is managed by J.P. Morgan and Jefferies, with closing expected on June 4, 2026, subject to usual conditions. This capital raise supports TETRA's growth in energy services and industrial chemicals sectors.
DBV Technologies has begun screening the first participant in its phase 2 THRIVE clinical trial to test the VIASKIN Peanut patch on infants aged 6 to 12 months with peanut allergies. The study aims to evaluate the patch's safety and effectiveness in ...
Cryptocurrency markets experienced a significant downturn, with Bitcoin falling about 6.8% to $66,018 and Ethereum dropping over 8% to $1,835. Major altcoins like Binance Coin, Solana, and Dogecoin also saw declines of 6-9%. This broad sell-off refle...
Robbins LLP is investigating Beta Bionics, Inc.'s officers and directors for potential violations of securities laws and breaches of fiduciary duties following the company's announcement of weaker-than-expected patient growth. Beta Bionics reported a...
The U.S. Trade Representative has proposed tariffs of up to 12.5% on imports from 60 countries, including major economies like China, the EU, and Japan, due to their failure to ban goods made with forced labor. This move aims to level the playing fie...
Robbins LLP is investigating whether officers and directors of Simulation Plus, Inc. violated securities laws and breached fiduciary duties following significant stock price drops in 2025. The company faced a 24% stock decline after lowering revenue ...
